Developer docs
API playgroundTry for free, no card

Search company profiles

Rennovia

Full company profile

uuid000ytxf

Namestring
Rennovia
Websiteurl
rennovia.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Rennovia was a chemical process technology development company headquartered in Menlo Park, California, founded in 2009. According to firmographic data, the firm focused on developing process technologies aimed at reducing production costs relative to incumbent petrochemical manufacturing routes. The company operated as a for-profit private entity with a headcount in the 11-50 range, positioning itself as a technology development venture in the industrial chemistry sector rather than a commercial-scale chemicals producer.

The company raised approximately $78.5 million across multiple funding rounds between 2009 and 2014, with the earliest round backed by 5AM Ventures and Versant Ventures. Subsequent rounds in 2013 and 2014 collectively added roughly $59.7 million of additional capital, though investor identities for those later rounds were not disclosed. No specific products, customer relationships, partnerships, management team details, or revenue figures are available in the source data, limiting visibility into the company's commercial progress and the specific process chemistries it pursued.

The company's current operating status is uncertain and indicative of cessation. The rennovia.com domain is currently listed for sale on HugeDomains for $4,695, strongly suggesting the company has wound down independent operations. No official acquisition, merger, or formal shutdown announcement was identified in available sources, leaving a significant diligence gap regarding the company's ultimate disposition, IP ownership, and any successor entity.

Short descriptiontext

Rennovia was a Menlo Park-based chemical process technology developer founded in 2009, focused on cost reduction versus incumbent petrochemical processes. It raised approximately $78.5 million in private funding between 2009 and 2014 before apparently ceasing independent operations.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
chemical process technology, petrochemical alternatives, bio-based chemicals, adipic acid production, green chemistry processes
Industry2 codes
PRIMARYIMAEADAC
C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid)
SECONDARYBPAHAIAF
Industrial & Process Engineering Consulting
NAICS code2 codes
  • Other Basic Organic Chemical Manufacturing32519
  • Basic Chemical Manufacturing3251
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Miscellaneous Chemical Products2890
Product category
Industrial Chemical Process Technology
Social media profiles1 record
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Rennovia develops proprietary chemical process technologies aimed at reducing manufacturing costs versus conventional petrochemical-based routes. The company's work targets industrial chemical production, with public references indicating involvement in process routes relevant to adipic acid and related nylon 6,6 intermediates. The firm operated as a process technology development company rather than a bulk chemical manufacturer.

Differentiator
Functional benefit
Problem solved
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Cargill supplies bio-based feedstocks (e.g., corn-derived glucose) and operates in bio-based chemical ventures (including a previous bio-based 3PD/PDO business). It is an enabling/ecosystem player that supplies the renewable carbon inputs underpinning Rennovia-type bio-process chemistry.

TypeBroad incumbent
Description

BASF is the world's largest chemical producer and a major player in adipic acid, hexamethylenediamine, and nylon 6,6 intermediates — the very markets Rennovia targets. It is the principal incumbent whose petrochemical processes Rennovia's bio-based technology aims to undercut.

3Verdezyne
TypeDirect peer
Description

Verdezyne used engineered yeast strains to produce bio-based adipic acid — directly competing with Rennovia's own bio-adipic acid process target. Same feedstock strategy, same target molecule, same renewable-versus-petrochemical displacement thesis.

4BioAmber
TypeDirect peer
Description

BioAmber developed bio-based succinic acid process technology as a renewable alternative to petrochemical routes, and similarly pursued licensing and joint-venture models with chemical producers. Comparable in technology and target chemistry applications to Rennovia.

TypeBroad incumbent
Description

INVISTA is a leading global producer of adipic acid, hexamethylenediamine, and nylon intermediates, and the largest integrated nylon 6,6 value chain participant. Represents the dominant petrochemical benchmark against which any Rennovia bio-based process must compete on cost.

TypeDirect peer
Description

Amyris uses synthetic biology to produce renewable specialty ingredients and chemical intermediates historically derived from petroleum. Both target displacement of petrochemical-derived products with bio-based alternatives via proprietary microbial/catalytic processes.

TypeDirect peer
Description

Codexis engineers enzymes and biocatalysts used in industrial chemical manufacturing processes, including pharmaceutical and chemical intermediates. Both companies commercialize catalytic IP into existing chemical manufacturing assets, sharing a process-technology licensing go-to-market against petrochemical incumbents.

TypeBroad incumbent
Description

Novozymes is the global leader in industrial enzymes and microbial solutions used in chemical and bio-based manufacturing processes. Relevant as a broad incumbent supplying the type of biological catalysts Rennovia's process technology relies on.

9Myriant (now GC Innovation America)
TypeEmerging player
Description

Myriant developed bio-based succinic acid using fermentation routes and pursued commercial offtake with chemical manufacturers. Operates in the same bio-based chemical intermediate space, though its target molecule differs from Rennovia's adipic acid focus.

TypeDirect peer
Description

Genomatica develops bio-based process technology for producing widely-used chemicals (e.g., butanediol) from renewable feedstocks via proprietary catalysts and microbes. It is the closest direct analog to Rennovia, with the same bio-routing strategy against incumbent petrochemical processes and a similar licensing-oriented business model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rennovia

Industrial Chemical Process Technologyrennovia.com

Rennovia was a Menlo Park-based chemical process technology developer founded in 2009, focused on cost reduction versus incumbent petrochemical processes. It raised approximately $78.5 million in private funding between 2009 and 2014 before apparently ceasing independent operations.

What Rennovia does

Rennovia was a chemical process technology development company headquartered in Menlo Park, California, founded in 2009. According to firmographic data, the firm focused on developing process technologies aimed at reducing production costs relative to incumbent petrochemical manufacturing routes. The company operated as a for-profit private entity with a headcount in the 11-50 range, positioning itself as a technology development venture in the industrial chemistry sector rather than a commercial-scale chemicals producer.

The company raised approximately $78.5 million across multiple funding rounds between 2009 and 2014, with the earliest round backed by 5AM Ventures and Versant Ventures. Subsequent rounds in 2013 and 2014 collectively added roughly $59.7 million of additional capital, though investor identities for those later rounds were not disclosed. No specific products, customer relationships, partnerships, management team details, or revenue figures are available in the source data, limiting visibility into the company's commercial progress and the specific process chemistries it pursued.

The company's current operating status is uncertain and indicative of cessation. The rennovia.com domain is currently listed for sale on HugeDomains for $4,695, strongly suggesting the company has wound down independent operations. No official acquisition, merger, or formal shutdown announcement was identified in available sources, leaving a significant diligence gap regarding the company's ultimate disposition, IP ownership, and any successor entity.

Rennovia firmographics

Firmographics
Name
Rennovia
Website
https://rennovia.com
Company type
Private
Founded year
2009
Operating status
Closed
Headcount range
1–10 employees
Short description
Rennovia was a Menlo Park-based chemical process technology developer founded in 2009, focused on cost reduction versus incumbent petrochemical processes. It raised approximately $78.5 million in private funding between 2009 and 2014 before apparently ceasing independent operations.
Ownership category
akta.pro rank

Rennovia industry classification

Industry
Product category
Industrial Chemical Process Technology
NAICS
Other Basic Organic Chemical Manufacturing (32519), Basic Chemical Manufacturing (3251)
SIC
Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAEADAC
C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid)
SECONDARYBPAHAIAF
Industrial & Process Engineering Consulting

Keywords

  • Chemical process technology
  • Petrochemical alternatives
  • Bio-based chemicals
  • Adipic acid production
  • Green chemistry processes

Where Rennovia is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Markets served

Rennovia business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations

Rennovia product offering

Product offering

Core offering

Rennovia develops proprietary chemical process technologies aimed at reducing manufacturing costs versus conventional petrochemical-based routes. The company's work targets industrial chemical production, with public references indicating involvement in process routes relevant to adipic acid and related nylon 6,6 intermediates. The firm operated as a process technology development company rather than a bulk chemical manufacturer.

Differentiator

Problem solved

Functional benefit

Companies that use Rennovia

Customer profile

Ideal customer profiles1 record

Rennovia technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Rennovia partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights2 records

Rennovia competitors and assessment

Company assessment

Others

  • Cargill: Cargill supplies bio-based feedstocks (e.g., corn-derived glucose) and operates in bio-based chemical ventures (including a previous bio-based 3PD/PDO business). It is an enabling/ecosystem player that supplies the renewable carbon inputs underpinning Rennovia-type bio-process chemistry.

Broad incumbents

  • BASF: BASF is the world's largest chemical producer and a major player in adipic acid, hexamethylenediamine, and nylon 6,6 intermediates — the very markets Rennovia targets. It is the principal incumbent whose petrochemical processes Rennovia's bio-based technology aims to undercut.
  • INVISTA: INVISTA is a leading global producer of adipic acid, hexamethylenediamine, and nylon intermediates, and the largest integrated nylon 6,6 value chain participant. Represents the dominant petrochemical benchmark against which any Rennovia bio-based process must compete on cost.
  • Novozymes: Novozymes is the global leader in industrial enzymes and microbial solutions used in chemical and bio-based manufacturing processes. Relevant as a broad incumbent supplying the type of biological catalysts Rennovia's process technology relies on.

Direct peers

  • Verdezyne: Verdezyne used engineered yeast strains to produce bio-based adipic acid — directly competing with Rennovia's own bio-adipic acid process target. Same feedstock strategy, same target molecule, same renewable-versus-petrochemical displacement thesis.
  • BioAmber: BioAmber developed bio-based succinic acid process technology as a renewable alternative to petrochemical routes, and similarly pursued licensing and joint-venture models with chemical producers. Comparable in technology and target chemistry applications to Rennovia.
  • Amyris: Amyris uses synthetic biology to produce renewable specialty ingredients and chemical intermediates historically derived from petroleum. Both target displacement of petrochemical-derived products with bio-based alternatives via proprietary microbial/catalytic processes.
  • Codexis: Codexis engineers enzymes and biocatalysts used in industrial chemical manufacturing processes, including pharmaceutical and chemical intermediates. Both companies commercialize catalytic IP into existing chemical manufacturing assets, sharing a process-technology licensing go-to-market against petrochemical incumbents.
  • Genomatica: Genomatica develops bio-based process technology for producing widely-used chemicals (e.g., butanediol) from renewable feedstocks via proprietary catalysts and microbes. It is the closest direct analog to Rennovia, with the same bio-routing strategy against incumbent petrochemical processes and a similar licensing-oriented business model.

Emerging players

  • Myriant (now GC Innovation America): Myriant developed bio-based succinic acid using fermentation routes and pursued commercial offtake with chemical manufacturers. Operates in the same bio-based chemical intermediate space, though its target molecule differs from Rennovia's adipic acid focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights5 records

Customer concentration

Rennovia social profiles

Digital presence

Rennovia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rennovia leadership team

Management profile

Number of profiles

Rennovia funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rennovia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rennovia

What does Rennovia do?

Rennovia develops proprietary chemical process technologies aimed at reducing manufacturing costs versus conventional petrochemical-based routes. The company's work targets industrial chemical production, with public references indicating involvement in process routes relevant to adipic acid and related nylon 6,6 intermediates. The firm operated as a process technology development company rather than a bulk chemical manufacturer.

When was Rennovia founded?

Rennovia was founded in 2009. It employs 1 to 10 people.

Where is Rennovia based?

Rennovia is headquartered in Menlo Park, United States, in the North America region.

Who are Rennovia's main competitors?

Cargill is listed as an others. Broad incumbents are BASF, INVISTA and Novozymes. Direct peers are Verdezyne, BioAmber, Amyris, Codexis and Genomatica. Myriant (now GC Innovation America) is listed as an emerging player.

Does Rennovia have an API?

No public API is recorded for Rennovia.

What industry is Rennovia in?

Rennovia's product category is Industrial Chemical Process Technology. Its primary akta.pro industry code is IMAEADAC, C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid), with a secondary code of BPAHAIAF, Industrial & Process Engineering Consulting. Its NAICS code is 32519 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals